Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Blitz

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Oncotarget|January 12, 2023
Intraventricular immunovirotherapy; a translational step forwardJoshua D Bernstock, Sarah Blitz, Kyung-Don Kang, et al.
Neurosurgery|June 20, 2024
Benign Natural Progression of Small Cavernous Carotid Aneurysms Suggests Limited Clinical Utility of Serial Longitudinal Follow-upRohan Jha, Maryann Zhao, Jack Y Ghannam, et al.
Journal of Neurosurgery|March 13, 2026
Predicting tremor control and side effects during focused ultrasound thalamotomy using MR temperature imagingNathan McDannold, Melissa M J Chua, Sarah Blitz, et al.
Journal of Neurosurgery|March 11, 2023
Applying objective metrics to neurosurgical skill development with simulation and spaced repetition learningFaith C Robertson, Christopher J Stapleton, Jean-Valery C E Coumans, et al.
World Neurosurgery|July 27, 2024
The Neurovascular Disease Management Course: A Medical Student Opportunity for Early Exposure and Technical Development in Vascular NeurosurgeryJustin Gelman, Jean Filo, Felipe Ramirez-Velandia, et al.
Pharmacology & Therapeutics|April 29, 2022
Clinical advances in oncolytic virotherapy for pediatric brain tumorsGelare Ghajar-Rahimi, Kyung-Don Kang, Stacie K Totsch, et al.
Pharmacology & Therapeutics|October 10, 2025
Treatment strategies for leptomeningeal disease in patients with breast cancerLennard Spanehl, Thomas Grinda, Rishab Ramapriyan, et al.
Molecular Cancer Therapeutics|May 6, 2024
Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time DependentStacie K Totsch, Andrew S Ishizuka, Kyung-Don Kang, et al.
Science Translational Medicine|September 6, 2023
Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomasPierpaolo Peruzzi, Christine Dominas, Geoffrey Fell, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Oncotarget|January 12, 2023
Intraventricular immunovirotherapy; a translational step forwardJoshua D Bernstock, Sarah Blitz, Kyung-Don Kang, et al.
Neurosurgery|June 20, 2024
Benign Natural Progression of Small Cavernous Carotid Aneurysms Suggests Limited Clinical Utility of Serial Longitudinal Follow-upRohan Jha, Maryann Zhao, Jack Y Ghannam, et al.
Journal of Neurosurgery|March 13, 2026
Predicting tremor control and side effects during focused ultrasound thalamotomy using MR temperature imagingNathan McDannold, Melissa M J Chua, Sarah Blitz, et al.
Journal of Neurosurgery|March 11, 2023
Applying objective metrics to neurosurgical skill development with simulation and spaced repetition learningFaith C Robertson, Christopher J Stapleton, Jean-Valery C E Coumans, et al.
World Neurosurgery|July 27, 2024
The Neurovascular Disease Management Course: A Medical Student Opportunity for Early Exposure and Technical Development in Vascular NeurosurgeryJustin Gelman, Jean Filo, Felipe Ramirez-Velandia, et al.
Pharmacology & Therapeutics|April 29, 2022
Clinical advances in oncolytic virotherapy for pediatric brain tumorsGelare Ghajar-Rahimi, Kyung-Don Kang, Stacie K Totsch, et al.
Pharmacology & Therapeutics|October 10, 2025
Treatment strategies for leptomeningeal disease in patients with breast cancerLennard Spanehl, Thomas Grinda, Rishab Ramapriyan, et al.
Molecular Cancer Therapeutics|May 6, 2024
Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time DependentStacie K Totsch, Andrew S Ishizuka, Kyung-Don Kang, et al.
Science Translational Medicine|September 6, 2023
Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomasPierpaolo Peruzzi, Christine Dominas, Geoffrey Fell, et al.
Pageof 1